Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Chemopreventive Effects of Germinated Rough Rice Crude Extract in Inhibiting Azoxymethane-Induced Aberrant Crypt Foci Formation in Sprague-Dawley Rats.

Saki E, Saiful Yazan L, Mohd Ali R, Ahmad Z.

Biomed Res Int. 2017;2017:9517287. doi: 10.1155/2017/9517287. Epub 2017 Jan 2.

2.

Influences and Practices in Colorectal Cancer Screening Among Health Care Providers Serving Northern Plains American Indians, 2011-2012.

Nadeau M, Walaszek A, Perdue DG, Rhodes KL, Haverkamp D, Forster J.

Prev Chronic Dis. 2016 Dec 15;13:E167. doi: 10.5888/pcd13.160267.

3.
4.

Warfarin Use During Fecal Occult Blood Testing: A Meta-Analysis.

Ashraf I, Paracha S, Paracha SU, Arif M, Choudhary A, Godfrey JD, Clark RE, Abdullah O, Matteson ML, Puli SR, Ibdah JA, Dabbagh O, Bechtold ML.

Gastroenterology Res. 2012 Apr;5(2):45-51. Epub 2012 Mar 20.

5.

Incidence trends of colorectal cancer in Iran during 2000-2009: A population-based study.

Abdifard E, Amini S, Bab S, Masroor N, Khachian A, Heidari M.

Med J Islam Repub Iran. 2016 Jun 5;30:382. eCollection 2016.

6.

Partnership for Healthier Asians: Disseminating Evidence-Based Practices in Asian-American Communities Using a Market-Oriented and Multilevel Approach.

Kim K, Quinn M, Chandrasekar E, Patel R, Lam H.

JMIR Res Protoc. 2016 Jun 16;5(2):e123. doi: 10.2196/resprot.5625.

7.

A multivariate cure model for left-censored and right-censored data with application to colorectal cancer screening patterns.

Hagar YC, Harvey DJ, Beckett LA.

Stat Med. 2016 Aug 30;35(19):3347-67. doi: 10.1002/sim.6934. Epub 2016 Mar 18.

PMID:
26990553
8.

Colorectal cancer screening at community health centers: A survey of clinicians' attitudes, practices, and perceived barriers.

Brown T, Lee JY, Park J, Nelson CA, McBurnie MA, Liss DT, Kaleba EO, Henley E, Harigopal P, Grant L, Crawford P, Carroll JE, Alperovitz-Bichell K, Baker DW.

Prev Med Rep. 2015 Sep 21;2:886-91. doi: 10.1016/j.pmedr.2015.09.003. eCollection 2015.

9.

Associations between contextual factors and colorectal cancer screening in a racially and ethnically diverse population in Texas.

Calo WA, Vernon SW, Lairson DR, Linder SH.

Cancer Epidemiol. 2015 Dec;39(6):798-804. doi: 10.1016/j.canep.2015.09.012. Epub 2015 Oct 18.

10.

Providers' knowledge, attitudes, and practices related to colorectal cancer control in Brazil.

Perin DM, Saraiya M, Thompson TD, de Moura L, Simoes EJ, Parra DC, Brownson RC.

Prev Med. 2015 Dec;81:373-9. doi: 10.1016/j.ypmed.2015.09.021. Epub 2015 Oct 9.

11.

Label-free surface-enhanced Raman spectroscopy for detection of colorectal cancer and precursor lesions using blood plasma.

Feng S, Wang W, Tai IT, Chen G, Chen R, Zeng H.

Biomed Opt Express. 2015 Aug 24;6(9):3494-502. doi: 10.1364/BOE.6.003494. eCollection 2015 Sep 1.

12.

Competition in Colon Cancer Screening? What Is the Role of Colonoscopy?

Hoffman A, Teubner D, Kiesslich R.

Viszeralmedizin. 2014 Feb;30(1):18-25. doi: 10.1159/000358445. Review.

13.

Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.

Imperiale TF, Monahan PO, Stump TE, Glowinski EA, Ransohoff DF.

Ann Intern Med. 2015 Sep 1;163(5):339-46. doi: 10.7326/M14-1720.

14.

Older adults' preferences for colorectal cancer-screening test attributes and test choice.

Kistler CE, Hess TM, Howard K, Pignone MP, Crutchfield TM, Hawley ST, Brenner AT, Ward KT, Lewis CL.

Patient Prefer Adherence. 2015 Jul 15;9:1005-16. doi: 10.2147/PPA.S82203. eCollection 2015.

15.

Familial colorectal cancer screening: When and what to do?

Del Vecchio Blanco G, Paoluzi OA, Sileri P, Rossi P, Sica G, Pallone F.

World J Gastroenterol. 2015 Jul 14;21(26):7944-53. doi: 10.3748/wjg.v21.i26.7944. Review.

16.

Obtaining research biopsies during pediatric colonoscopy: Safety and adverse events.

Mait-Kaufman J, Kahn S, Tomer G.

World J Gastrointest Endosc. 2015 Jun 25;7(7):736-40. doi: 10.4253/wjge.v7.i7.736.

17.

Dietary polyamine intake and colorectal cancer risk in postmenopausal women.

Vargas AJ, Ashbeck EL, Wertheim BC, Wallace RB, Neuhouser ML, Thomson CA, Thompson PA.

Am J Clin Nutr. 2015 Aug;102(2):411-9. doi: 10.3945/ajcn.114.103895. Epub 2015 Jul 1.

18.

Preferences for genetic testing for colorectal cancer within a population-based screening program: a discrete choice experiment.

Veldwijk J, Lambooij MS, Kallenberg FG, van Kranen HJ, Bredenoord AL, Dekker E, Smit HA, de Wit GA.

Eur J Hum Genet. 2016 Mar;24(3):361-6. doi: 10.1038/ejhg.2015.117. Epub 2015 Jun 3.

19.

Addressing Low Colorectal Cancer Screening in African Americans: Using Focus Groups to Inform the Development of Effective Interventions.

May FP, Whitman CB, Varlyguina K, Bromley EG, Spiegel BM.

J Cancer Educ. 2016 Sep;31(3):567-74. doi: 10.1007/s13187-015-0842-z.

PMID:
25963898
20.

Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.

Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, Kamineni A, Weaver DL, Tiro JA; Population-based Research Optimizing Screening through Personalized Regimens Consortium.

J Natl Cancer Inst. 2015 May 7;107(6):djv120. doi: 10.1093/jnci/djv120. Print 2015 Jun.

Supplemental Content

Support Center